NCT05622058 2023-02-27A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast CancerAileron Therapeutics, Inc.Phase 1 Terminated6 enrolled
NCT00005787 2012-06-01Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's LymphomaNorthwestern UniversityPhase 1 Terminated3 enrolled